Related references
Note: Only part of the references are listed.Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Novel genetic tools reveal Cdk5's major role in golgi fragmentation in Alzheimer's disease
Kai-Hui Sun et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Identification of nuclear import mechanisms for the neuronal Cdk5 activator
Xinrong Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of CDK5/P25 formation/inhibition in neurodegeneration
Antoni Camins et al.
DRUG NEWS & PERSPECTIVES (2006)
Cdk5, a therapeutic target for Alzheimer's disease?
LH Tsai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
Chronic exposure to U18666A induces apoptosis in cultured murine cortical neurons
NS Cheung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Lactacystin-induced apoptosis of cultured mouse cortical neurons is associated with accumulation of PTEN in the detergent-resistant membrane fraction
NS Cheung et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Cdk5 is a key factor in tau aggregation and tangle formation in vivo
W Noble et al.
NEURON (2003)
Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau
M Hashiguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation
P Kerokoski et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3β
F Liu et al.
FEBS LETTERS (2002)
Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35
P Kerokoski et al.
MOLECULAR BRAIN RESEARCH (2002)
Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35
K Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
p35/Cdk5 pathway mediates soluble amyloid-β peptide-induced tau phosphorylation in vitro
T Town et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29
H Patzke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The Cdk5-p35 kinase,associates with the Golgi apparatus and regulates membrane traffic
G Paglini et al.
EMBO REPORTS (2001)
The molecular bases of Alzheimer's disease and other neurodegenerative disorders
RB Maccioni et al.
ARCHIVES OF MEDICAL RESEARCH (2001)
Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain
A Takashima et al.
NEUROSCIENCE LETTERS (2001)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry
ET Lund et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells
R Nath et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Impaired proteasome function in Alzheimer's disease
JN Keller et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25
G Kusakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau
K Sobue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Neurotoxicity induces cleavage of p35 to p25 by calpain
MS Lee et al.
NATURE (2000)
Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases
BT Chua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
